HCP, Inc. (HCP) Analysts See $0.43 EPS

September 30, 2018 - By Jason Dias

HCP, Inc. (NYSE:HCP) LogoInvestors sentiment decreased to 0.93 in 2018 Q2. Its down 0.07, from 1 in 2018Q1. It fall, as 40 investors sold HCP, Inc. shares while 174 reduced holdings. 60 funds opened positions while 140 raised stakes. 399.08 million shares or 0.06% less from 399.33 million shares in 2018Q1 were reported.
Cullen Capital Mgmt Limited Liability Corporation owns 0.43% invested in HCP, Inc. (NYSE:HCP) for 441,280 shares. Apg Asset Mgmt Nv owns 234,175 shares. Kcm Inv Advsr Ltd Limited Liability Company accumulated 18,743 shares or 0.03% of the stock. 21,623 were reported by Eqis. North Star Investment Mgmt Corporation accumulated 1,329 shares or 0% of the stock. Lpl Fincl reported 0.01% of its portfolio in HCP, Inc. (NYSE:HCP). Weiss Multi holds 0.59% or 947,989 shares. Blair William Communication Il owns 0.01% invested in HCP, Inc. (NYSE:HCP) for 42,490 shares. First Trust L P holds 524,486 shares or 0.03% of its portfolio. 8,425 are held by Carnegie Cap Asset Mgmt. Duncker Streett & Company Incorporated accumulated 21,427 shares. Dupont Cap holds 0.04% or 72,090 shares. Qs Llc reported 40,075 shares. Quantbot L P holds 0% or 8 shares. 1,343 are held by Sandy Spring Fincl Bank.

Since May 14, 2018, it had 1 buy, and 0 insider sales for $502,180 activity.

Analysts expect HCP, Inc. (NYSE:HCP) to report $0.43 EPS on November, 1.They anticipate $0.05 EPS change or 10.42 % from last quarter’s $0.48 EPS. HCP’s profit would be $204.87 million giving it 15.30 P/E if the $0.43 EPS is correct. After having $0.47 EPS previously, HCP, Inc.’s analysts see -8.51 % EPS growth. The stock increased 2.61% or $0.67 during the last trading session, reaching $26.32. About 3.56M shares traded or 31.00% up from the average. HCP, Inc. (NYSE:HCP) has declined 10.64% since September 30, 2017 and is downtrending. It has underperformed by 26.26% the S&P500.

HCP, Inc. (NYSE:HCP) Ratings Coverage

Among 9 analysts covering HCP Inc (NYSE:HCP), 3 have Buy rating, 0 Sell and 6 Hold. Therefore 33% are positive. HCP Inc had 12 analyst reports since April 13, 2018 according to SRatingsIntel. Morgan Stanley maintained HCP, Inc. (NYSE:HCP) rating on Thursday, August 16. Morgan Stanley has “Equal-Weight” rating and $25 target. On Monday, May 21 the stock rating was downgraded by Raymond James to “Hold”. Bank of America maintained HCP, Inc. (NYSE:HCP) rating on Monday, September 17. Bank of America has “Buy” rating and $28 target. The company was maintained on Monday, August 6 by Stifel Nicolaus. The firm has “In-Line” rating by Evercore given on Monday, September 10. The stock of HCP, Inc. (NYSE:HCP) has “Hold” rating given on Friday, April 13 by Jefferies. Robert W. Baird maintained it with “Neutral” rating and $26 target in Thursday, August 9 report. The company was maintained on Thursday, June 14 by Morgan Stanley. As per Monday, May 21, the company rating was downgraded by Evercore. The stock of HCP, Inc. (NYSE:HCP) has “Overweight” rating given on Friday, September 28 by Cantor Fitzgerald.

HCP, Inc. is a fully integrated real estate investment trust that invests primarily in real estate serving the healthcare industry in the United States. The company has market cap of $12.54 billion. HCP owns a large-scale portfolio diversified across multiple sectors, led by senior housing, life science and medical office. It has a 204.03 P/E ratio. Recognized as a global leader in sustainability, HCP has been a publicly-traded firm since 1985 and was the first healthcare REIT selected to the S&P 500 index.

More news for HCP, Inc. (NYSE:HCP) were recently published by: Nasdaq.com, which released: “3 Top Dividend Stocks With Yields Over 5%” on September 30, 2018. Seekingalpha.com‘s article titled: “HCP, Inc.: Should You Still Buy This 5.5%-Yielding Healthcare REIT?” and published on September 03, 2018 is yet another important article.

HCP, Inc. (NYSE:HCP) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: